Re: Lilly Medchem Rules [message #869 is a reply to message #859] |
Thu, 23 April 2020 19:29 ![Go to previous message Go to previous message](/forum/theme/myThemeWithHFCSS/images/up.png) ![Go to next message Go to previous message](/forum/theme/myThemeWithHFCSS/images/down.png) |
nbehrnd
Messages: 215 Registered: June 2019
|
Senior Member |
|
|
The publication you cite (ACS' Author Choice, thus open access) was published in 2012,
J. Med. Chem. currently is aware of 141 publications citing this work; some you might
know. The history of commits in the repository notes for Dec 14, 2017 «First working
version for version 2», too.
Are there additions / modifications to the set of 275 MedChem rules of the 2012
publication which you would like to suggest to consider today? The approach
suggested indeed is complementary to the approach of druglikeness in DW,[1] in turn
borrowed from the earlierr OSIRIS Property Explorer.
[1] http://www.openmolecules.org/properties/properties.html#drug score
[Updated on: Thu, 23 April 2020 20:32] Report message to a moderator
|
|
|